SCHEMBL2373272

SCHEMBL2373272

Cc1ccc(S(=O)(=O)OCCOCCOCCOc2ccc(/C=C/c3ccc(N(C)C)cc3)cn2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 11/20 0.43
MAPT P10636 2/20 0.43
SNCA P37840 1/20 0.43
ALDH1A1 P00352 2/20 0.40
POLB P06746 1/20 0.40
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
APOBEC3A P31941 2/20 0.38
RAB9A P51151 2/20 0.38
APOBEC3G Q9HC16 2/20 0.38
GFER P55789 2/20 0.38
NPC1 O15118 1/20 0.38
GAA P10253 1/20 0.38
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA9 Q16790 1/20 0.36
CYP24A1 Q07973 1/20 0.36
PTGS1 P23219 1/20 0.35
LMNA P02545 1/20 0.35
MAPK1 P28482 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2373282 1.00 APP (0.43) APPMAPTSNCAALDH1A1POLB
SCHEMBL12330048 0.97 APP (0.45) APPMAPTSNCAALDH1A1POLB
SCHEMBL32661288 0.90 APP (0.41) APPMAPTSNCAALDH1A1POLB
SCHEMBL17022266 0.88 APP (0.39) APPMAPTSNCAALDH1A1POLB
SCHEMBL2984823 0.85 APP (0.37) APPMAPTSNCACA12CA1
SCHEMBL29963770 0.85 APP (0.37) APPMAPTSNCACA12CA1
SCHEMBL2984820 0.85 APP (0.37) APPMAPTSNCACA12CA1
SCHEMBL15586799 0.78 APP (0.44) APPMAPTSNCAALDH1A1POLB
SCHEMBL13863163 0.78 APP (0.53) APPMAPTSNCAALDH1A1MEN1
SCHEMBL13431716 0.78 APP (0.53) APPMAPTSNCAALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2363392-B1 STYRYLPYRIDINE DERIVATIVES AND THEIR USE FOR BINDING AND IMAGING AMYLOID PLAQUES UNIV PENNSYLVANIA (US) 2017-05-03 EP disclosed
US-8840866-B2 Styrylpyridine derivatives and their use for binding and imaging amyloid plaques THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2014-09-23 US disclosed
US-8506929-B2 Styrylpyridine derivatives and their use for binding and imaging amyloid plaques THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2013-08-13 US disclosed
US-20130129624-A1 STYRYLPYRIDINE DERIVATIVES AND THEIR USE FOR BINDING AND IMAGING AMYLOID PLAQUES THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2013-05-23 US disclosed
EP-1999109-B1 STYRYLPYRIDINE DERIVATIVES AND THEIR USE FOR BINDING AND IMAGING AMYLOID PLAQUES UNIV PENNSYLVANIA (US) 2011-12-28 EP disclosed
EP-2363391-A1 Styrylpyridine derivatives and their use for binding and imaging amyloid plaques The Trustees of The University of Pennsylvania (US) 2011-09-07 EP disclosed
EP-2363392-A1 Styrylpyridine derivatives and their use for binding and imaging amyloid plaques The Trustees of The University of Pennsylvania (US) 2011-09-07 EP disclosed
US-7687052-B2 radiolabeling; neurodegenerative diseases THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2010-03-30 US disclosed
US-20090123369-A1 Styrylpyridine Derivatives and Their Use for Binding and Imaging Amyloid Plaques THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2009-05-14 US disclosed
EP-1999109-A2 STYRYLPYRIDINE DERIVATIVES AND THEIR USE FOR BINDING AND IMAGING AMYLOID PLAQUES The Trustees Of The University Of Pennsylvania (US) 2008-12-10 EP disclosed
US-20080038195-A1 radiolabeling; neurodegenerative diseases THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2008-02-14 US disclosed
WO-2007126733-A2 STYRYLPYRIDINE DERIVATIVES AND THEIR USE FOR BINDING AND IMAGING AMYLOID PLAQUES THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2007-11-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130129624-A1 STYRYLPYRIDINE DERIVATIVES AND THEIR USE FOR BINDING AND IMAGING AMYLOID PLAQUES APP, APBA1, PSEN1 APP 1/4885MAPT 7/4885SNCA 33/4885
US-20080038195-A1 radiolabeling; neurodegenerative diseases APP, PSEN1, HTT APP 1/4885MAPT 6/4885SNCA 10/4885
US-20090123369-A1 Styrylpyridine Derivatives and Their Use for Binding and Imaging Amyloid Plaques APP, APBA1, PSEN1 APP 1/4885MAPT 7/4885SNCA 33/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.